Hydrogen Therapy May Help Protect Cells in High Blood Pressure Pregnancy
- Authors
- Li-Li Guo, Z. Guan, H. Li, Xiang Yang
- Journal
- Cellular and Molecular Biology
- Year
- 2016
- DOI
- 10.14715/cmb/2016.62.6.11
- Study Type
- Cell Culture
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Hypertensive Disorders in Pregnancy
- Body System
- Reproductive
TL;DR
Hydrogen treatment can reduce cell damage and inflammation in pregnant women with high blood pressure by influencing certain cell processes and molecules.
Key Finding
Hydrogen reduced harmful reactive oxygen species in placental cells and prevented cell death by suppressing specific damage-signaling pathways, suggesting a potential mechanism for how hydrogen might help treat high blood pressure in pregnancy.
Summary
This laboratory study examined how hydrogen affects cells from the placenta in pregnant women with high blood pressure. Researchers found that hydrogen reduced harmful molecules called reactive oxygen species (unstable atoms that damage cells) and prevented placental cells from dying prematurely by turning off specific damage signals in the cells. The study was conducted in cell cultures, not in people or animals.
Practical Takeaway
While this cell-culture study identifies a possible way hydrogen might work against pregnancy-related high blood pressure, it is very early-stage research that cannot yet inform clinical use. Much more research—including animal studies and human trials—would be needed before any conclusions about hydrogen's safety or effectiveness in pregnant women could be drawn.
Abstract
Hypertensive disorders complicating pregnancy (HDCP) is one of the most serious medical disorders during pregnancy. Hydrogen is a therapeutic antioxidant and used to treat HDCP effectively. However, the molecular mechanism about the effect of hydrogen on HDCP still remains unclear. In this study, we found ROS content in HDCP group was significantly higher than that in the control and was reduced markedly in the presence of 100μmol/L hydrogen. IL6, Caspase3, Bax1, P-JAK2, P-Stat3 and P-p38 expression was much higher than the control, and was notably decreasedby the application of 100μmol/L hydrogen. Bcl2 expression in HDCP group was notably lower than the control and was increased by 100 μmol/L hydrogen. The apoptosis rate of cytotrophoblast cells was decreased, andratio of cytotrophoblast cells at G1 and G2 phase was increased and decreased by hydrogen, respectively. All those data indicated a potential molecular mechanism of hydrogen-mediated treatment in HDCP.